Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$89,500
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gengos Andrew +$90K Chief Financial Officer 1 filing
Date Insider Transaction Shares Price Value Owned after
2021-08-03 Feinberg Peter Director Conversion · Series B Preferred Stock −30,646 0
2021-08-03 Feinberg Peter Director Conversion · Series B Preferred Stock −30,646 0
2021-08-03 Zeskind Benjamin J. President and CEO Conversion +49,099 2,598,171
2021-08-03 Zeskind Benjamin J. President and CEO Purchase +2,098 $15.00 $31K 2,600,269
2021-08-03 Zeskind Benjamin J. President and CEO Conversion · Series A Preferred Stock −40,928 0
2021-08-03 Zeskind Benjamin J. President and CEO Conversion · Series B Preferred Stock −8,171 0
2021-08-03 KEATING LAURIE Director Purchase +7,000 $15.00 $105K 7,000
2021-08-03 Hall Brett Matthew Chief Scientific Officer Conversion +5,040 5,040
2021-08-03 Hall Brett Matthew Chief Scientific Officer Purchase +1,353 $15.00 $20K 6,393
2021-08-03 Hall Brett Matthew Chief Scientific Officer Conversion · Series A Preferred Stock −1,636 0
2021-08-03 Hall Brett Matthew Chief Scientific Officer Conversion · Series B Preferred Stock −3,404 0
2021-08-03 CARPENTER ROBERT J Director Conversion +217,173 823,839
2021-08-03 CARPENTER ROBERT J Director Purchase +325,000 $15.00 $4.9M 1,148,839
2021-08-03 CARPENTER ROBERT J Director Conversion · Series A Preferred Stock −94,585 0
2021-08-03 CARPENTER ROBERT J Director Conversion · Series B Preferred Stock −122,588 0
2021-08-03 Bookman Michael General Counsel and Secretary Purchase +1,402 $15.00 $21K 1,402
2021-08-03 BERMAN ANN E Director Purchase +3,500 $15.00 $53K 3,500
2021-08-03 Barrett Scott Chief Medical Officer Conversion +5,996 5,996
2021-08-03 Barrett Scott Chief Medical Officer Purchase +667 $15.00 $10K 6,663
2021-08-03 Barrett Scott Chief Medical Officer Conversion · Series A Preferred Stock −3,273 0

Page 11 of 12 · 226 trades